# Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression

> **NCT03349528** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sheppard Pratt Health System** · enrollment: 80 (estimated)

## Conditions studied

- Bipolar Depression

## Interventions

- **BIOLOGICAL:** Probiotic Supplement
- **BIOLOGICAL:** Inert Compound

## Key facts

- **NCT ID:** NCT03349528
- **Lead sponsor:** Sheppard Pratt Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-11
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03349528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03349528, "Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03349528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*